Literature DB >> 34967410

"Bind, cleave and leave": multiple turnover catalysis of RNA cleavage by bulge-loop inducing supramolecular conjugates.

Bahareh Amirloo1, Yaroslav Staroseletz2, Sameen Yousaf1, David J Clarke1, Tom Brown3, Harmesh Aojula1, Marina A Zenkova2, Elena V Bichenkova1.   

Abstract

Antisense sequence-specific knockdown of pathogenic RNA offers opportunities to find new solutions for therapeutic treatments. However, to gain a desired therapeutic effect, the multiple turnover catalysis is critical to inactivate many copies of emerging RNA sequences, which is difficult to achieve without sacrificing the sequence-specificity of cleavage. Here, engineering two or three catalytic peptides into the bulge-loop inducing molecular framework of antisense oligonucleotides achieved catalytic turnover of targeted RNA. Different supramolecular configurations revealed that cleavage of the RNA backbone upon sequence-specific hybridization with the catalyst accelerated with increase in the number of catalytic guanidinium groups, with almost complete demolition of target RNA in 24 h. Multiple sequence-specific cuts at different locations within and around the bulge-loop facilitated release of the catalyst for subsequent attacks of at least 10 further RNA substrate copies, such that delivery of only a few catalytic molecules could be sufficient to maintain knockdown of typical RNA copy numbers. We have developed fluorescent assay and kinetic simulation tools to characterise how the limited availability of different targets and catalysts had restrained catalytic reaction progress considerably, and to inform how to accelerate the catalytic destruction of shorter linear and larger RNAs even further.
© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34967410      PMCID: PMC8789077          DOI: 10.1093/nar/gkab1273

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  100 in total

Review 1.  microRNAs in vertebrate physiology and human disease.

Authors:  Tsung-Cheng Chang; Joshua T Mendell
Journal:  Annu Rev Genomics Hum Genet       Date:  2007       Impact factor: 8.929

Review 2.  Mapping nucleic acid structure by hydroxyl radical cleavage.

Authors:  Thomas D Tullius; Jason A Greenbaum
Journal:  Curr Opin Chem Biol       Date:  2005-04       Impact factor: 8.822

3.  'Dual' peptidyl-oligonucleotide conjugates: Role of conformational flexibility in catalytic cleavage of RNA.

Authors:  Yaroslav Staroseletz; Aled Williams; Kepa K Burusco; Irfan Alibay; Valentin V Vlassov; Marina A Zenkova; Elena V Bichenkova
Journal:  Biomaterials       Date:  2016-10-03       Impact factor: 12.479

Review 4.  Givosiran: First Approval.

Authors:  Lesley J Scott
Journal:  Drugs       Date:  2020-02       Impact factor: 9.546

5.  SimRNA: a coarse-grained method for RNA folding simulations and 3D structure prediction.

Authors:  Michal J Boniecki; Grzegorz Lach; Wayne K Dawson; Konrad Tomala; Pawel Lukasz; Tomasz Soltysinski; Kristian M Rother; Janusz M Bujnicki
Journal:  Nucleic Acids Res       Date:  2015-12-19       Impact factor: 16.971

6.  The involvement of human ribonucleases H1 and H2 in the variation of response of cells to antisense phosphorothioate oligonucleotides.

Authors:  Anneloor L M A ten Asbroek; Marjon van Groenigen; Marleen Nooij; Frank Baas
Journal:  Eur J Biochem       Date:  2002-01

7.  Genetics of gene expression and its effect on disease.

Authors:  Valur Emilsson; Gudmar Thorleifsson; Bin Zhang; Amy S Leonardson; Florian Zink; Jun Zhu; Sonia Carlson; Agnar Helgason; G Bragi Walters; Steinunn Gunnarsdottir; Magali Mouy; Valgerdur Steinthorsdottir; Gudrun H Eiriksdottir; Gyda Bjornsdottir; Inga Reynisdottir; Daniel Gudbjartsson; Anna Helgadottir; Aslaug Jonasdottir; Adalbjorg Jonasdottir; Unnur Styrkarsdottir; Solveig Gretarsdottir; Kristinn P Magnusson; Hreinn Stefansson; Ragnheidur Fossdal; Kristleifur Kristjansson; Hjortur G Gislason; Tryggvi Stefansson; Bjorn G Leifsson; Unnur Thorsteinsdottir; John R Lamb; Jeffrey R Gulcher; Marc L Reitman; Augustine Kong; Eric E Schadt; Kari Stefansson
Journal:  Nature       Date:  2008-03-16       Impact factor: 49.962

8.  Kinetics of heterochiral strand displacement from PNA-DNA heteroduplexes.

Authors:  Nandini Kundu; Brian E Young; Jonathan T Sczepanski
Journal:  Nucleic Acids Res       Date:  2021-06-21       Impact factor: 16.971

9.  Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency.

Authors:  Olga A Patutina; Svetlana K Gaponova Miroshnichenko; Aleksandra V Sen'kova; Innokenty A Savin; Daniil V Gladkikh; Ekaterine A Burakova; Alesya A Fokina; Mikhail A Maslov; Elena V Shmendel'; Mattew J A Wood; Valentin V Vlassov; Sidney Altman; Dmitry A Stetsenko; Marina A Zenkova
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-07       Impact factor: 12.779

Review 10.  RNAi-based therapeutics-current status, challenges and prospects.

Authors:  Katrin Tiemann; John J Rossi
Journal:  EMBO Mol Med       Date:  2009-06       Impact factor: 12.137

View more
  1 in total

1.  Bulge-Forming miRNases Cleave Oncogenic miRNAs at the Central Loop Region in a Sequence-Specific Manner.

Authors:  Olga Patutina; Daria Chiglintseva; Bahareh Amirloo; David Clarke; Svetlana Gaponova; Valentin Vlassov; Elena Bichenkova; Marina Zenkova
Journal:  Int J Mol Sci       Date:  2022-06-12       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.